GPT Healthcare Limited Approves 37th AGM, Recommends 15% Final Dividend
GPT Healthcare Limited, through its Board of Directors, announced key corporate actions following a meeting held on May 18, 2026. The Board approved plans for the company’s 37th Annual General Meeting (AGM), recommended a final dividend for the financial year 2025-26, and outlined the necessary book closure dates for the proceedings.The Board approved convening the 37th AGM on Thursday, August 6, 2026. The meeting will be held through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), with the Registered Office of the Company designated as the deemed venue.
Regarding shareholder benefits, the Board of Directors recommended a Final Dividend of 15% for the financial year ended March 31, 2026. This dividend translates to ₹1.50 per equity share, based on a face value of ₹10 per share. The payout is subject to the approval of the shareholders during the ensuing 37th AGM. Should the dividend be approved by the members, the payment is scheduled within 30 days of its declaration at the AGM.
To facilitate the annual general meeting and the dividend determination, the company approved a book closure period spanning July 31, 2026, through August 6, 2026. The definitive dates for shareholders are as follows:
| Event | Date | Purpose |
|---|---|---|
| Cut-off Date | July 30, 2026 | Determining dividend entitlement for the AGM |
| Record Date | July 30, 2026 | Determining dividend entitlement for the AGM |
| Book Closure Period | July 31, 2026, to August 6, 2026 | Purpose of the 37th AGM |
| 37th Annual General Meeting | August 6, 2026 | Voting and AGM Proceedings |
The company confirmed that the record date and cut-off date for the purpose of determining dividend entitlement remain July 30, 2026.
GPTHEALTH Stock Price Movement
Shares of GPT Healthcare Limited today slipped by 1.11% to settle at ₹138.76 in post-market trading. The equity settled on a volume of 77,663 shares, finding support in range relative to its intraday low of ₹137.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.